NEW DELHI, December 19, 2018
NEW DELHI, December 19, 2018 /PRNewswire/ --
According to a new report Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2018-2024), published by KBV Research, the Minimally Invasive Glaucoma Surgery (MIGS) Devices market is expected to attain a market size of $1,180.7 million by 2024, growing at a CAGR of 30.4% during the forecast period. Minimally Invasive Glaucoma Surgery has emerged out to be a novel prospect in the treatment of glaucoma and have been touted safer and quicker recovery compared to traditional means. The advent of MIGS devices recently has revolutionized the patients care with any condition of glaucoma alone or in conjunction with cataract. The safer and quicker recovery times have piqued the interest of glaucoma patient globally. Rapid rise in geriatric population that is more susceptible to glaucoma and other similar eye disorders is the prime factor to drive the market growth.
North America conquered the leading position in the Minimally Invasive Glaucoma Surgery (MIGS) Devices market owing to the preferred surgical modality as it limits the complications associated with the traditional procedures. However, Asia pacific region evaluated to grow at a significant pace at a CAGR of 31.8% during the forecast period. The high populous base of countries such as India and China and growing geriatric population contributes to the robust growth in Asia Pacific region.
Access Full Report: https://kbvresearch.com/minimally-invasive-glaucoma-surgery-migs-devices-market
The Glaucoma in Conjunction with Cataract segment dominated Market by surgery in 2017, while registering a CAGR of 29.8% during the forecast period. MIGS usually require shorter operation time and also allows more rapid recovery compared to others. These MIGS are combined with cataract extraction (CE) with patients having mild to moderate cataracts and glaucoma. For instance, iStent is widely used for MIGS procedures performed in conjunction with Cataract surgery. The advent of MIGS devices recently has revolutionized the patients care with any condition of glaucoma alone or in conjunction with cataract, thereby propelling the market growth.
Trabecular Meshwork generated the highest revenue based on the target in 2017, registering a CAGR of 29.8% during the forecast period. This is owing to highest number of MIGS surgeries performed in the Trabecular Meshwork to create the path for the proper drainage of aqueous humor. The iStent Trabecular Micro-Bypass Stent is widely used to perform such surgeries.
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key influencing factors of the global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market have been discussed in the report along with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
Minimally Invasive Glaucoma Surgery (MIGS) Devices Segmentation
By End User
Unique Offerings from KBV Research
Knowledge Based Value Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.
Our aim is to transform and customize our services to address the fast changing business needs of our clients. With innovative methods, we seek to empower our research tools with new capabilities that would eventually bring about customer delight, as we understand that businesses evolve.
Mr. Alan D'Souza
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)